In vivo inhibitory effect of lanreotide (BIM 23014), a new somatostatin analog, on prostaglandin- and cholera toxin-stimulated intestinal fluid in the rat
- 1 March 1993
- Vol. 14 (2) , 297-301
- https://doi.org/10.1016/0196-9781(93)90044-h
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Effects of somatostatin analog SMS 201-995 on enterotoxigenic diarrheaDigestive Diseases and Sciences, 1991
- Mechanisms underlying the small intestinal fluid secretion caused by arachidonic acid, prostaglandin E1 and prostaglandin E2 in the rat in vivoActa Physiologica Scandinavica, 1987
- Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatinLife Sciences, 1987
- Evidence that PGE2 stimulates intestinal epithelial cell adenylate cyclase by a receptor-mediated mechanismDigestive Diseases and Sciences, 1987
- Effect of adding albumin to solutions of somatostatin on inhibiting pentagastrin-stimulated acid secretion in dogsDigestive Diseases and Sciences, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic choleraDigestive Diseases and Sciences, 1982
- N‐terminally extended somatostatin: The primary structure of somatostatin‐28FEBS Letters, 1980
- INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONEThe Lancet, 1974
- Cholera Enterotoxin: Failure of Anti-inflammatory Agents to Prevent Cyclic AMP AccumulationNature, 1973